Literature DB >> 19787239

Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer.

Xiao-Bo Long1, Guang-Bin Sun, Shuang Hu, Geng-Tian Liang, Nan Wang, Xin-Hao Zhang, Ping-Ping Cao, Hong-Tao Zhen, Yong-Hua Cui, Zheng Liu.   

Abstract

MicroRNAs (miRNAs) are endogenously expressed non-coding RNAs, which are involved in the gene expression regulation. Lethal-7a (let-7a) is a founding member of miRNA family and recently it was found to be associated with several cancers, such as lung and colon cancers. In the present study, we found that let-7a miRNA expression was significantly downregulated both in human laryngeal squamous cancer tissues and in Hep-2 cells, a laryngeal cancer cell line, as compared with adjacent normal tissues and BEAS-2B cells, respectively. Moreover, we found that let-7a expression levels were significantly further decreased in non-differentiated (G3) cancer tissues as compared with moderately and well differentiated cancer tissues (G2 and G1), although no significant difference in let-7a expression levels between the cancer specimens with different T stages or specimens from patients with different lymph node metastasis status was revealed. In Hep-2 cells, let-7a mimics transfection markedly suppressed proliferation and induced apoptosis of Hep-2 cells under the treatment of diamminedichloroplatinum or not and downregulated RAS and c-MYC protein expression without affecting the mRNA levels. In parallel, RAS and c-MYC protein levels were found significantly upregulated only in cancer tissues with downregulated let-7a expression. Thus, we propose that let-7a may be a tumor suppressor in laryngeal cancer by inhibiting cell growth, inducing cell apoptosis and downregulating the oncogenes expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787239     DOI: 10.3892/or_00000554

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  32 in total

Review 1.  Prospects of miRNA-based therapy for pancreatic cancer.

Authors:  Priya Pai; Satyanarayana Rachagani; Chandrakanth Are; Surinder K Batra
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

Review 2.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

Review 3.  MicroRNA in chronic rhinosinusitis and allergic rhinitis.

Authors:  Xin-Hao Zhang; Ya-Na Zhang; Zheng Liu
Journal:  Curr Allergy Asthma Rep       Date:  2014-02       Impact factor: 4.806

4.  Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.

Authors:  Cheng-Ming Hsu; Pai-Mei Lin; Yu-Ming Wang; Zong-Jyun Chen; Sheng-Fung Lin; Ming-Yu Yang
Journal:  Tumour Biol       Date:  2012-07-19

5.  LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c.

Authors:  Qingjun Yang; Jin Sun; Yifei Ma; Chunjie Zhao; Jijun Song
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

Review 6.  MicroRNA replacement therapy for cancer.

Authors:  Jon C Henry; Ana Clara P Azevedo-Pouly; Thomas D Schmittgen
Journal:  Pharm Res       Date:  2011-08-31       Impact factor: 4.200

7.  MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion.

Authors:  Lanying Sun; Jin Liang; Qibao Wang; Zhaoyuan Li; Yi Du; Xin Xu
Journal:  Cell Prolif       Date:  2016-08-30       Impact factor: 6.831

Review 8.  miRNAs in head and neck cancer revisited.

Authors:  Rahul Nagadia; Pratibala Pandit; William B Coman; Justin Cooper-White; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2013-01-22       Impact factor: 6.730

9.  TRBP alters human precursor microRNA processing in vitro.

Authors:  Ho Young Lee; Jennifer A Doudna
Journal:  RNA       Date:  2012-09-24       Impact factor: 4.942

10.  Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.

Authors:  Chiao-Chun Liao; Ming-Yi Ho; Shu-Mei Liang; Chi-Ming Liang
Journal:  Autophagy       Date:  2018-08-17       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.